Among the KIRs, KIR3DL2, an inhibitory receptor expressed on both NK cells and CD4+ T lymphocytes, plays a critical role in the pathogenesis of ankylosing spondylitis. Here, KIR3DL2 is linked to ankylosing spondylitis.